– SWITZERLAND, Vevey – Nestlé (SWX: NESN) today announced the current Head of International Business at Nestlé Health Science Anna Mohl as CEO of Nestlé Health Science and as EVP and member of the Executive Board of Nestlé S.A., effective January 1, 2024, replacing Greg Behar who will leave as of December 31, 2023.
“On behalf of our Board of Directors and Executive Board, I would like to recognize Greg’s work in shaping and expanding Nestlé Health Science. At the same time, we are thrilled to announce Anna Mohl as the next CEO of Nestlé Health Science. Anna brings a deep understanding of nutrition and health with a strong focus on consumers and patients around the world. She is an inspirational leader with a stellar track record who is ideally positioned to drive the growth and profitability of this business.” said Mark Schneider, CEO Nestlé.
About Anna Mohl
Anna Mohl has been with Nestlé for more than 20 years, starting with marketing and innovation roles at Gerber, Nestlé’s U.S. Infant Nutrition business. She joined Nestlé Health Science at its inception in 2010, where she led U.S. Medical Nutrition marketing and Medical Nutrition sales before becoming CEO of Nestlé Health Science U.S. She was promoted to her current role in January 2021, where she leads Nestlé Health Science’s global business in all markets outside the U.S.
SOURCE: https://www.nestle.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
